BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28589183)

  • 21. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
    Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
    Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
    Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
    Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements.
    Roedl JB; Prabhakar HB; Mueller PR; Colen RR; Blake MA
    Acad Radiol; 2009 Feb; 16(2):218-26. PubMed ID: 19124108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
    Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer.
    Lai S; Su T; He X; Lin Z; Chen S
    Oncotarget; 2018 Jan; 9(2):2797-2809. PubMed ID: 29416812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
    Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
    Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S
    Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia.
    Oh SE; Park S; Ahn S; An JY; Lee JH; Sohn TS; Bae JM; Choi MG
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.
    Suh YS; Han DS; Kong SH; Lee HJ; Kim YT; Kim WH; Lee KU; Yang HK
    Ann Surg; 2012 May; 255(5):908-15. PubMed ID: 22504190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route.
    Scheepers JJ; van der Peet DL; Veenhof AA; Cuesta MA
    Dis Esophagus; 2009; 22(1):42-8. PubMed ID: 19196265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study.
    Han WH; Eom BW; Yoon HM; Reim D; Kim YW; Kim MS; Lee JM; Ryu KW
    BMC Cancer; 2019 Jul; 19(1):719. PubMed ID: 31331305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and prognosis in patients with adenocarcinoma of esophagogastric junction with lymph node metastasis of Siewert II/III.
    Zheng Z; Shang Y; Xu R; Zhang H; Yin J; Zhang J; Zhang Z
    Int J Clin Exp Pathol; 2020; 13(5):1262-1269. PubMed ID: 32509102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Honda M; Kaito A; Daiko H; Kinoshita T
    Anticancer Res; 2014 Aug; 34(8):4391-7. PubMed ID: 25075076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
    Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.
    Fang WL; Wu CW; Chen JH; Lo SS; Hsieh MC; Shen KH; Hsu WH; Li AF; Lui WY
    Ann Surg Oncol; 2009 Dec; 16(12):3237-44. PubMed ID: 19636628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and prediction model of long time survival of patients with stage M1 Siewert type II esophagogastric junction adenocarcinoma.
    Zhang J; Liu D
    Transl Cancer Res; 2021 May; 10(5):2002-2008. PubMed ID: 35116522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.